How much sodium reduction is needed to meaningfully reduce hypertension risk?
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
Cutting sodium intake by roughly 1.5–2.0 grams of elemental sodium per day produces clinically meaningful reductions in blood pressure for many people, and guideline targets center on 2,300 mg/day or lower with 1,500 mg/day considered ideal for high‑risk groups (elderly, Black people, those with hypertension) [1][2][3]. Large meta‑analyses and randomized trials show an approximately linear dose–response: each large decrement in sodium intake produces several mmHg of systolic BP lowering and lowers cardiovascular risk when applied population‑wide, but very low intakes have been controversially linked to harms in some observational studies, so public‑health strategy favors moderate, sustained reductions and targeted substitution strategies [1][4][5][6].
1. What “meaningful” means in clinical terms: blood‑pressure and event impact
Meaningful BP reduction is commonly framed as a drop of a few mmHg in clinic systolic pressure because even small average shifts across a population translate into fewer strokes and heart attacks; trial and pooled data show that modest sodium reductions — on the order of about 1.75 g/day of sodium (≈4.4 g salt) — were associated with mean systolic/diastolic falls of roughly 4.2/2.1 mmHg overall and larger falls (≈5.4/2.8 mmHg) in people with hypertension [6][4]. A pooled regression of randomized trials found that very large reductions (every 100 mmol/day urinary sodium reduction, roughly 2.3 g sodium) corresponded with around a 5.6 mmHg systolic fall (95% CI ≈4.5–6.6 mmHg), indicating a near‑linear dose–response where greater reductions produce bigger effects [1].
2. Guideline targets and practical thresholds to aim for
Major clinical bodies and programs recommend upper limits that define policy and individual goals: population guidance often centers on reducing habitual intake to about 2,400 mg/day with further benefit at 1,500 mg/day especially for high‑risk individuals — the AHA and DASH literature explicitly endorse 1,500 mg/day as the ideal target to lower BP beyond 2,300 mg/day [3][2]. The WHO and public‑health reviews prioritise nationwide sodium reduction policies to shift average intake downward because the greatest overall public‑health gains come from modest but sustained population reductions rather than extreme individual restriction [7][4].
3. How much reduction is realistically effective — short answer
For individuals and populations, reducing intake by about 1.5–2.0 g of sodium per day (1,500–2,000 mg) from typical Western averages (often >3,000 mg/day) produces clear, measurable BP benefit and lowers downstream cardiovascular risk when implemented at scale [8][4][1]. Even smaller, self‑performed reductions show benefit in randomized settings for people with essential hypertension, and community interventions that substitute potassium‑enriched salts have demonstrated reductions in stroke and major cardiovascular events in older hypertensive populations [9][10].
4. Caveats, controversies, and tailoring the goal
Not all evidence is uniform: some observational cohorts report a J‑shaped relationship with higher mortality at both very high and very low sodium excretions, prompting debate about harms of extreme restriction and the methodological limits of observational sodium measures [5][6]. Randomized trials and meta‑analyses, however, support modest-to-moderate reductions for BP and CVD prevention, and professional groups stress that targets should be individualized—older adults and people with hypertension are prioritized for lower targets whereas population approaches focus on shifting averages via reformulation of processed foods and salt substitutes [4][7][3].
5. Practical implication: what public‑health and clinicians can do now
Meaningful risk reduction requires both individual counseling (aim for ≤2,300 mg/day and strive for 1,500 mg/day if high risk) and structural change: lowering sodium in processed foods, using potassium salt substitutes where safe, and public education — interventions that have succeeded in trials and large cluster studies show the greatest promise for reducing stroke and cardiovascular events at scale [2][10][7]. Where evidence is limited or contested (extremely low sodium thresholds and long‑term mortality), policymakers and clinicians should favour moderate, sustainable reductions backed by randomized evidence while monitoring vulnerable groups for adverse effects [5][6].